Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TORONTO, March 07, 2016 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (NASDAQ:CYNA) (TSX:CTH), a specialty central nervous system pharmaceutical company developing and preparing to commercialize a...
-
TORONTO, March 01, 2016 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (NASDAQ:CYNA) (TSX:CTH), a specialty central nervous system pharmaceutical company developing and preparing to commercialize a...
-
TORONTO, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (NASDAQ:CYNA) (TSX:CTH) today announced its President and CEO, Anthony Giovinazzo, will present an overview of the Company's...
-
Pivotal Trial of Cynapsus’ Under-the-Tongue Apomorphine Formulation Will Include Technology-Enabled Sub-Study to Gather and Analyze Objective Patient Data on Disease Progression and Medication...
-
TORONTO, Jan. 04, 2016 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (“Cynapsus” or the “Company”) (NASDAQ:CYNA) (TSX:CTH), a specialty central nervous system (“CNS”) pharmaceutical company...
-
TORONTO, Dec. 10, 2015 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (NASDAQ:CYNA) (TSX:CTH), a specialty central nervous system ("CNS") pharmaceutical company developing and preparing to...
-
TORONTO, Dec. 8, 2015 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. ("Cynapsus") (NASDAQ:CYNA) (TSX:CTH), a specialty central nervous system ("CNS") pharmaceutical company developing and preparing to...
-
TORONTO, Nov. 19, 2015 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (NASDAQ:CYNA) (TSX:CTH), a specialty CNS pharmaceutical company developing and preparing to commercialize a fast-acting,...
-
TORONTO, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (NASDAQ:CYNA) (TSX:CTH) today announced it will present an overview of the company's Parkinson's disease program and outlook at...
-
TORONTO, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (NASDAQ:CYNA) (TSX:CTH) ("Cynapsus" or the "Company"), a specialty central nervous system ("CNS") pharmaceutical company...